Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-10 Sale |
2023-04-12 4:51 pm |
Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
16,544,113 | $0.12 | $1,985,294 | 200,000 (Indirect) |
View |
| 2023-01-20 Sale |
2023-01-24 4:08 pm |
Pear Therapeutics Inc. | PEAR | O'Brien Ronan GC, CCO & Secretary |
12,162 | $1.13 | $13,743 | 18,638 (Direct) |
View |
| 2023-01-20 Sale |
2023-01-24 4:08 pm |
Pear Therapeutics Inc. | PEAR | Snow Ellen Chief Accounting Officer |
8,027 | $1.13 | $9,071 | 23,318 (Direct) |
View |
| 2023-01-20 Sale |
2023-01-24 4:08 pm |
Pear Therapeutics Inc. | PEAR | Strandberg Julia Chief Commercial Officer |
12,688 | $1.13 | $14,337 | 28,612 (Direct) |
View |
| 2023-01-20 Sale |
2023-01-24 4:08 pm |
Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer |
8,690 | $1.13 | $9,820 | 43,310 (Direct) |
View |
| 2023-01-20 Sale |
2023-01-24 4:07 pm |
Pear Therapeutics Inc. | PEAR | GUIFFRE CHRISTOPHERD T CFO, COO, Treas., & Asst. Sec. |
19,540 | $1.13 | $22,080 | 29,960 (Direct) |
View |
| 2023-01-20 Sale |
2023-01-24 4:07 pm |
Pear Therapeutics Inc. | PEAR | Jeffery Katherine Chief People Officer |
7,096 | $1.13 | $8,018 | 8,304 (Direct) |
View |
| 2023-01-20 Sale |
2023-01-24 4:07 pm |
Pear Therapeutics Inc. | PEAR | Maricich Yuri Chief Medical Officer |
12,162 | $1.13 | $13,743 | 94,333 (Direct) |
View |
| 2023-01-20 Sale |
2023-01-24 4:06 pm |
Pear Therapeutics Inc. | PEAR | McCann Corey President and CEO |
34,731 | $1.13 | $39,246 | 10,883,264 (Indirect Direct) |
View |
| 2022-11-11 Sale |
2022-11-15 8:32 pm |
Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
105,281 | $2.7381 | $288,267 | 3,907,624 (Indirect) |
View |
| 2022-10-31 Sale |
2022-11-02 7:49 pm |
Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
54,209 | $2.7688 | $150,096 | 3,911,835 (Indirect) |
View |
| 2022-09-14 Sale |
2022-09-16 6:03 pm |
Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
558,168 | $1.8764 | $1,047,322 | 3,914,004 (Indirect) |
View |
| 2022-09-06 Sale |
2022-09-08 8:01 pm |
Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
770,000 | $2.0543 | $1,581,835 | 3,936,331 (Indirect) |
View |
| 2022-08-16 Sale |
2022-08-18 8:05 pm |
Pear Therapeutics Inc. | PEAR | 5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner |
400,000 | $1.6501 | $660,060 | 3,967,131 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-15 Option Award |
2023-02-17 4:14 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Snow Ellen VP, Chief Accounting Officer |
239,864 | $0 | 239,864 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:14 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer |
952,380 | $0 | 952,380 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:14 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | O'Brien Ronan CCO, GC, & Secretary |
1,295,238 | $0 | 1,295,238 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:13 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Maricich Yuri Chief Medical Officer |
1,333,333 | $0 | 1,333,333 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:13 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Strandberg Julia Chief Commercial Officer |
1,409,523 | $0 | 1,409,523 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:12 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | GUIFFRE CHRISTOPHERD T CFO, COO, Treas., & Asst. Sec. |
2,285,714 | $0 | 2,285,714 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:12 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | McCann Corey President and CEO |
2,857,142 | $0 | 2,857,142 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:12 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Wicks Timothy A Director |
52,380 | $0 | 52,380 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:11 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | SCHLICHTING NANCY M Director |
66,666 | $0 | 66,666 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:11 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Reddy Kirthiga Director |
61,904 | $0 | 61,904 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:10 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Rajaraman Shivakumar Director |
52,380 | $0 | 52,380 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:10 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Mango Paul Director |
52,380 | $0 | 52,380 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 4:09 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Bauerlein Alison Director |
71,428 | $0 | 71,428 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 6:42 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer |
22,000 | $0 | 96,667 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 5:05 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Maricich Yuri Chief Medical Officer |
30,800 | $0 | 169,028 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 5:03 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | McCann Corey President and CEO |
88,000 | $0 | 11,096,662 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 5:03 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | GUIFFRE CHRISTOPHERD T CFO, COO, Treas., & Asst. Sec. |
49,500 | $0 | 150,000 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 5:02 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Snow Ellen Chief Accounting Officer |
20,320 | $0 | 72,601 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 5:01 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Strandberg Julia Chief Commercial Officer |
33,000 | $0 | 108,300 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 5:01 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | O'Brien Ronan GC, CCO & Secretary |
30,800 | $0 | 93,333 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 5:01 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Jeffery Katherine Chief People Officer |
15,400 | $0 | 46,667 (Direct) |
View |
| 2022-12-09 Other |
2022-12-13 6:00 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | LJ10 LLC KLP SPAC 1 LLC 10% Owner |
430,000 | $0 | 12,927,026 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-09 5:02 pm |
N/A 2028-09-20 |
Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer |
15,000 | $0 | 120,234 (Direct) |
View |
| 2022-12-09 Exercise |
2022-12-09 5:02 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Brenner Erin K. Chief Product Dev. Officer |
15,000 | $1 | 120,234 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:13 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Reddy Kirthiga Director |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:13 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | Mango Paul Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-16 4:12 pm |
N/A N/A |
Pear Therapeutics Inc. | PEAR | SCHLICHTING NANCY M Director |
100,000 | $0 | 100,000 (Direct) |
View |